精品国产一区二区桃色

Journal News

JBC: New insights into the molecular weapons of the plant microbiome

Sasha Mushegian
Sept. 1, 2018

Like all organisms, plants are associated with bacterial communities in which helpful and harmful bacteria compete for dominance. Among the weapons of these warring bacteria are molecular syringes that some bacteria can use to inject toxins into others. In published in the Journal of Biological Chemistry, researchers at in Canada pinpointed the identity of one such toxin used by a soil-dwelling bacterium that protects plants from disease.

The NAD-degrading enzyme Tne2 is secreted through the type VI secretion system of the plant-protective bacterium Pseudomonas protegens.Courtesy of John Whitney/McMaster University

The bacterium Pseudomonas protegens can kill soil-dwelling plant pathogens, including fungi and bacteria, that attack the roots of important crops such as cotton. P. protegens releases diverse antimicrobial compounds into the soil, but was curious specifically about the compounds that it was injecting directly into other bacteria through the type VI secretion system, or T6SS.

The T6SS “is this molecular nanomachine that injects toxic protein into other species of bacteria and kills them,” Whitney said. “Plant protective bacteria that have (T6SS) can protect plants from pathogens better relative to (bacteria) that don’t have it.”

and , undergraduate students from the working with Whitney on a co-op work-study assignment, spearheaded the discovery that the toxic protein used by P. protegens against other bacteria acts on a molecule found in nearly all living cells: nicotinamide adenine dinucleotide, or NAD+.

NAD+ is a cofactor, or “helper” molecule, in many biochemical reactions. By injecting a protein that destroys NAD+, P. protegens is able to kill other bacteria.

The team then investigated the genome sequences of hundreds of other bacteria to see how widespread the strategy of targeting NAD+ is in microbial warfare. They found that many bacteria with secretion systems carry genes similar to the one encoding the NAD-targeting toxin.

“We started to see that this isn’t just a way of killing that is enacted by plant-protective bacteria,” Whitney said. “If you look at the distribution of this (protein) among all sequenced bacteria, it appears that many different bacteria in many different environmental niches use this mode of action to outcompete other bacteria.”

The abundance of these toxins in nature raises questions: How do different bacteria in different environments evolve to resist this toxin? Are NAD-targeting toxins more effective against some bacterial species than others? Understanding the diversity of bacterial weapons is an active area of study among agricultural researchers who would like to develop better ways to fight plant diseases.

“The identification and characterization of antibacterial toxins produced by plant-protective bacteria may one day allow us to engineer these bacteria to have enhanced ability to suppress pathogens,” Whitney said.

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Sasha Mushegian

Sasha Mushegian is a postdoctoral fellow at Georgetown University. Follow her on Twitter.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.